This page is also available in:
Français
Complete a short questionnaire about a condition that you or a loved one may have, and find out if you (or they) might qualify for a clinical research study that could help improve your health.
Take Our Study Questionnaire for ongoing clinical research studies
Canadian Health & Wellness
Explore health guides on various medical conditions, news about drug development, regulatory updates from Health Canada and the FDA, and other health-related topics we think you’ll find valuable.
This page is also available in: FrançaisThe FDA has approved a safer dosing schedule for Eli Lilly’s Alzheimer’s drug, Kisunla, which could make it more appealing to doctors and patients. The updated schedule reduces the risk of a serious side effect called ARIA-E—brain swelling caused by anti-amyloid drugs. Originally, Kisunla was given in higher doses
Read More
This page is also available in: FrançaisOver the past 50 years, vaccines have saved millions of children’s lives by protecting them from deadly diseases like measles, polio, and diphtheria. But a major new study shows this progress is now stalling—and even reversing in some countries—putting millions of children worldwide at risk. The study, led by
Read More
This page is also available in: FrançaisFluoride has been added to public water systems in the U.S. since 1945 to help prevent tooth decay, a benefit recognized widely by public health experts. Fluoride strengthens tooth enamel and helps reduce harmful bacteria in the mouth. However, some recent concerns have questioned its safety, especially when exposure
Read More
This page is also available in: FrançaisWelcome to our series of blogs honoring Clinical Trials Day 2025, recognized on May 20th! Clinical trials are vital to advancing medicine—and joining one can be a powerful way to contribute to science and potentially benefit from new treatments. But how do you actually get started? Here’s a simple guide
Read More
This page is also available in: FrançaisThe U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on treatment for adults with chronic obstructive pulmonary disease (COPD) who continue to have flare-ups despite using triple inhaled therapy. Nucala is the first biologic drug specifically approved for COPD patients with an “eosinophilic phenotype”—a group
Read More
This page is also available in: FrançaisWelcome to our series of blogs honoring Clinical Trials Day 2025, recognized on May 20th! Clinical trials are essential studies conducted to evaluate the safety, efficacy, and effectiveness of medical interventions, including drugs, treatments, devices, and diagnostic procedures. These trials follow a structured and rigorous process to generate reliable
Read More
This page is also available in: FrançaisAstraZeneca is making big moves with its inhaler, Breztri Aerosphere, aiming to expand its use beyond chronic obstructive pulmonary disease (COPD) to also treat asthma. This could bring the company closer to its sales goal of $3 to $5 billion a year. Breztri is a 3-in-1 inhaler that combines
Read More
This page is also available in: FrançaisA recent international study has found that a single dose of a new RSV vaccine, called RSVPreF3 OA, can protect adults aged 60 and older from serious lung infections caused by the respiratory syncytial virus (RSV) for up to three seasons. The study involved over 24,000 older adults across
Read More
This page is also available in: FrançaisMore Americans are turning to diabetes drugs like Ozempic, not for diabetes, but for weight loss. A new study shows that the use of GLP-1 medications among U.S. adults without diabetes more than tripled between 2018 and 2022. In that time, annual spending on these drugs surged from $1.6
Read More
This page is also available in: FrançaisDonating blood may do more than just help others—it could also enhance the health of your own blood cells. A recent study suggests that frequent blood donation may encourage the growth of beneficial blood cell mutations, potentially lowering the risk of blood-related diseases. Researchers at the Francis Crick Institute
Read More
This page is also available in: FrançaisA recent survey by ixlayer and Ipsos reveals that patients expect pharmaceutical companies to do more than just develop medications—they want digital tools to improve healthcare access. Over 400 adults with chronic conditions like asthma, diabetes, and heart disease participated in the study, with nearly 75% saying they would
Read More
This page is also available in: FrançaisA recent study by Uppsala University and Chalmers University of Technology has found that coffee from many workplace coffee machines contains high levels of cholesterol-raising compounds. The research, published in Nutrition, Metabolism & Cardiovascular Diseases, highlights the difference between coffee brewed in these machines and coffee made using regular
Read More
This page is also available in: FrançaisCanada is increasing its supply of bird flu (avian influenza) vaccines, following similar actions in the U.S. and U.K. The Public Health Agency of Canada (PHAC) secured 500,000 doses of GSK’s Arepanrix H5N1 vaccine, which is based on proven flu shot technology. Canada’s health regulator has approved a change
Read More
This page is also available in: FrançaisThe FDA has approved Novo Nordisk’s drug Ozempic for a new use: reducing the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease (CKD). This approval is significant because Ozempic is now the first drug in
Read More
This page is also available in: FrançaisAs 2024 draws to a close, groundbreaking advancements have defined the year, spanning medicine, space exploration, and ancient history. Here are the top discoveries: 1. HIV Prevention Breakthrough The drug lenacapavir, used as an HIV preventative, achieved stunning success in trials, with up to 100% efficacy. Administered biannually as
Read More
This page is also available in: FrançaisNovo Nordisk is exploring a higher-dose version of semaglutide to enhance weight loss treatments. In a recent phase 3b clinical trial called STEP UP, a 7.2-mg weekly dose of semaglutide helped participants lose an average of 20.7% of their body weight over 72 weeks. This significantly outperformed the 2.4-mg
Read More
JoinAStudy.ca is your trusted resource, created by a network of Canadian physicians dedicated to advancing medicine through clinical research. We are committed to providing reliable health information and making it easier for you to participate in clinical trials.
The JoinAStudy community includes individuals who have participated in clinical research studies with our physicians or those interested in joining a study and receiving health-related updates. Why not join us?
Clinical research plays a vital role in advancing healthcare. By joining a study, you have the opportunity to:
- Make a Difference: Contribute to medical breakthroughs that benefit yourself and future generations.
- Gain Early Access to New Treatments: Be among the first to access potential new medications or treatments not yet widely available.
- Deepen Your Health Knowledge: Learn more about your specific condition and receive comprehensive medical care throughout the study.
- Contribute to Your Well-being: Receive additional medical attention and potentially improve your health through participation.
JoinAStudy is more than a research platform—it’s a community built on trust and dedication. Our study participants are the unsung heroes who drive medical progress forward. By joining our trusted community, you’ll receive updates on studies that may benefit you, your family, or friends. Whether or not there’s a study right for you now, you’ll be the first to know when new opportunities arise. And remember, you can leave our community anytime – just let us know, and we’ll respect your choice.
I haven’t actually started the study for Knee Osteoarthritis Pain and have already experienced a positive outcome.
While going through the initial interview, I mentioned I had been diagnosed with alcohol-induced fatty liver disease, but had been trying to reverse the damage by not consuming alcohol and by taking supplements to support my liver. The results of my required blood test came back and, amazing news, my liver function is now normal and even if I wasn’t accepted into the study I felt I had already received great benefit by receiving this news.
Vancouver, British Columbia -
I was very fortunate to participate in a clinical research study, not only because I have benefited from a new cholesterol-reducing drug, but also because of the relationship with the doctor’s office that developed out of the trial led to the early detection and treatment of a heart condition that might otherwise have been fatal in a few years.
Woodstock, Ontario -
I have participated in many asthma clinical research studies. You really feel like they [study staff] care about your health and they are there to provide support and suggestions regarding your health such as new drugs that may help you down the road. That is why I participate in these studies because I am always looking to improve my health.
Newmarket, Ontario -
The clinical trial I participated in was a very rewarding experience. The drug I was trailing was a positive for my condition. My provider of the study was very knowledgeable and extremely helpful. My appointments were always on time and conducted with the utmost care. A job well done.
Woodstock, Ontario -
Please note that these testimonials describe the experiences of a few study participants and may not accurately describe your experience.
